Altered B Cell Metabolic Pathways Characterize Type 1 Diabetes Progression
Holly Conway(University School), Jamie L. Felton(University School)
Cited by 2
Related Papers
Pharmacological inhibition of tyrosine protein-kinase 2 reduces islet inflammation and delays type 1 diabetes onset in mice
|EBioMedicine|2025|14
Pharmacological inhibition of tyrosine protein-kinase 2 reduces islet inflammation and delays type 1 diabetes onset in mice
|bioRxiv (Cold Spring Harbor Laboratory)|2024|3
Pharmacological Inhibition of Tyrosine Protein-Kinase 2 Reduces Islet Inflammation and Delays Type 1 Diabetes Onset in Mice
|SSRN Electronic Journal|2024|3
A parallax view of type 1 diabetes
|The Biochemist|2021|1